Vorapaxar in the Secondary Prevention of Atherothrombotic EventsDavid A. Morrow, Sabina A. Murphy, Eugene Braunwald et al.|New England Journal of Medicine|2012Cited by 941
Clinical Picture and Risk Prediction of Short-Term Mortality in Cardiogenic ShockVeli‐Pekka Harjola, Lars Køber, Tuukka Tarvasmäki et al.|European Journal of Heart Failure|2015Cited by 792
Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: The Multinational Observational Cohort on Acute Heart Failure (MOCA) studyJohan Lassus, Alexandre Mebazaa, Étienne Gayat et al.|International Journal of Cardiology|2013Cited by 237
Acute heart failure and cardiogenic shock: a multidisciplinary practical guidanceAlexandre Mebazaa, James L. Januzzi, Heli Tolppanen et al.|Intensive Care Medicine|2015Cited by 214
The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea studyAlexandre Mebazaa, Mihai Gheorghiade, Peter S. Pang et al.|European Heart Journal|2009Cited by 188